Clinical Trials Browser

Unknown × Observational × Neuromyelitis Optica × Clear all

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Encephalomyelitis, Acute Disseminated, Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica, Autoimmune Diseases of the Nervous System

NCT05245344 2022-02-17

Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study

Unknown

154 enrolled

Neuromyelitis Optica, Epstein-Barr Virus Infections, Multiple Sclerosis, Relapsing-Remitting

Clinical Trials

NIDBase

Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study